Reactogenicity of a third BNT162b2 mRNA COVID-19 vaccine among immunocompromised individuals and seniors - A nationwide survey
収録刊行物
-
- Clinical Immunology
-
Clinical Immunology 232 108860-, 2021-11
Elsevier BV